Side Chain Structure Determines Unique Physiologic and Therapeutic Properties of norUrsodeoxycholic Acid in Mdr2(−/−) Mice

24-norursodeoxycholic acid (norUDCA), a side chain–modified ursodeoxycholic acid derivative, has dramatic therapeutic effects in experimental cholestasis and may be a promising agent for the treatment of cholestatic liver diseases. We aimed to better understand the physiologic and therapeutic proper...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Halilbasic, Emina, Fiorotto, Romina, Fickert, Peter, Marschall, Hanns-Ulrich, Moustafa, Tarek, Spirli, Carlo, Fuchsbichler, Andrea, Gumhold, Judith, Silbert, Dagmar, Zatloukal, Kurt, Langner, Cord, Maitra, Uday, Denk, Helmut, Hofmann, Alan F., Strazzabosco, Mario, Trauner, Michael
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3569724/
https://ncbi.nlm.nih.gov/pubmed/19475687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.22891
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares